Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xab8
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 114M | $138M | 0% | Dec 2023 |
|
| Graham Capital Management | 73M | $89M | 32% | Dec 2023 |
|
| Aristeia Capital | 53M | $65M | -21% | Dec 2023 |
|
| D. E. Shaw & Co | 21M | $26M | 0% | Dec 2023 |
|
| Point72 Asset Management | 18M | $22M | 24% | Dec 2023 |
|
| Wells Fargo & Company | 17M | $21M | -8% | Dec 2023 |
|
| Lazard Asset Management | 16M | $20M | 34983% | Dec 2023 |
|
| 683 Capital Management | 15M | $18M | 0% | Dec 2023 |
|
| MacKay Shields | 14M | $18M | 0% | Dec 2023 |
|
| Wolverine Asset Management | 14M | $17M | 100% | Dec 2023 |
|
| Lord, Abbett & Co | 13M | $16M | 100% | Dec 2023 |
|
| Calamos Advisors | 10M | $12M | 0% | Dec 2023 |
|
| Weiss Asset Management LP[1 | 7.0M | $8.5M | 100% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 7.0M | $8.5M | 0% | Dec 2023 |
|
| SSI Investment Management | 4.8M | $5.7M | 100% | Dec 2023 |
|
| CSS | 3.7M | $4.4M | 70% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.8M | $3.4M | -17% | Dec 2023 |
|
| Highbridge Capital Management | 2.5M | $3.0B | -89% | Dec 2023 |
|
| New York State Common Retirement Fund | 2.1M | $2.5M | -28% | Dec 2023 |
|
| Man Group | 2.0M | $2.4M | -20% | Dec 2023 |
|
| Royal Bank of Canada | 1.7M | $2.0M | 19% | Dec 2023 |
|
| Aviva | 1.0M | $1.2M | 100% | Dec 2023 |
|
| Shenkman Capital Management | 750k | $913M | 100% | Dec 2023 |
|
| Bank of New York Mellon | 500k | $538k | 0% | Mar 2024 |
|
| Palisade Capital Management | 414k | $500k | 0% | Dec 2023 |
|
| Credit Suisse | 300k | $370k | 0% | Dec 2023 |
|
| Russell Investments | 185k | $224k | 100% | Dec 2023 |
|
| Context Capital Management | 110k | $133M | 1700% | Dec 2023 |
|
| First Hawaiian Bank | 95k | $102k | 0% | Mar 2024 |
|
| Fox Hill Wealth Management | 74k | $79k | 4% | Mar 2024 |
|
| Citigroup | 53k | $64k | 100% | Dec 2023 |
|
| Stonegate Investment Group | 12k | $13k | 0% | Mar 2024 |
|
| SG Americas Securities | 9.0k | $1.1M | -38% | Dec 2023 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Castle Creek Arbitrage | Sep 2023 | 10M | $9.6M |
| Polygon Management | Sep 2023 | 5.9M | $5.6M |
| Citadel Advisors | Sep 2023 | 5.5M | $5.3M |
| CNH Partners | Sep 2023 | 5.0M | $4.8M |
| Capstone Investment Advisors | Sep 2023 | 2.5M | $2.4M |
| Barclays | Sep 2023 | 700k | $673k |
| Bank of America Corporation | Sep 2023 | 425k | $406k |
| Aurum Wealth Management Group | Sep 2023 | 11k | $11k |